Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...
A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...
Researchers at Dana-Farber Cancer Institute have developed a breakthrough method to detect inflammation in the body using ...
The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III clinical trial involving patients with stage III colon cancer, which found that ...
Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...
What sets NiMe apart from other diets is that it is dominated by vegetables (such as leafy greens) and legumes (such as beans ...
Colon cancer is the third leading cause of cancer-related deaths worldwide, posing a significant global health challenge.
Experts hope to create a blood test to see which patients with inflammatory bowel disease are most at risk of bowel cancer.
The rising rate of colon cancer in young people can't be caused by diet alone, doctors say. Microplastics, sleep, and ...